Henry Schein (NASDAQ:HSIC) Price Target Cut to $72.00

Henry Schein (NASDAQ:HSICGet Free Report) had its price target decreased by Evercore ISI from $75.00 to $72.00 in a report released on Tuesday, Benzinga reports. The brokerage currently has an “in-line” rating on the stock. Evercore ISI’s target price points to a potential upside of 12.17% from the stock’s current price.

Several other brokerages have also issued reports on HSIC. Piper Sandler restated an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a research note on Friday, June 21st. UBS Group cut their price objective on Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, May 8th. Finally, Barrington Research reiterated an “outperform” rating and issued a $92.00 price objective on shares of Henry Schein in a report on Friday, July 5th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $80.73.

Get Our Latest Research Report on Henry Schein

Henry Schein Price Performance

Shares of HSIC opened at $64.19 on Tuesday. Henry Schein has a 1 year low of $60.01 and a 1 year high of $82.63. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The company has a market capitalization of $8.22 billion, a price-to-earnings ratio of 21.69, a price-to-earnings-growth ratio of 1.60 and a beta of 0.87. The business has a 50-day moving average of $68.78 and a 200-day moving average of $72.36.

Henry Schein (NASDAQ:HSICGet Free Report) last released its earnings results on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The business had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.21 billion. During the same quarter last year, the firm posted $1.21 earnings per share. The firm’s revenue was up 3.7% on a year-over-year basis. As a group, equities research analysts anticipate that Henry Schein will post 5.16 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Arizona State Retirement System grew its holdings in shares of Henry Schein by 0.4% during the 4th quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock worth $2,717,000 after acquiring an additional 149 shares during the period. Empirical Finance LLC grew its holdings in shares of Henry Schein by 3.5% during the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after acquiring an additional 160 shares during the period. Covestor Ltd grew its holdings in shares of Henry Schein by 12.8% during the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after acquiring an additional 171 shares during the period. Keene & Associates Inc. grew its holdings in shares of Henry Schein by 4.0% during the 1st quarter. Keene & Associates Inc. now owns 4,505 shares of the company’s stock worth $340,000 after acquiring an additional 175 shares during the period. Finally, Wahed Invest LLC grew its holdings in shares of Henry Schein by 9.2% during the 4th quarter. Wahed Invest LLC now owns 2,222 shares of the company’s stock worth $168,000 after acquiring an additional 187 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.